Evaluation of the safety and efficacy of Fiberoptic indicator (US100) in canaloplasty: a prospective, multicenter, non-inferiority, randomised controlled trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-17013843

Enrollment

Unknown

Registered

2017-12-11

Start date

2018-06-01

Completion date

Unknown

Last updated

2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open angle glaucoma

Interventions

A:Canaloplasty with ophthalmic optical fibre catheter(UC100)

B:Canaloplasty with micro-catheter(iTrack 250A)

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. Open angle glaucoma including primary open angle glaucoma, pigmentary glaucoma or intraocular hypertention with poor medication response; 3. IOP = 21 mm Hg; 4. Informed consent given and consent form signed.

Exclusion criteria

Exclusion criteria: 1. Angle closure glaucoma or patients with a history of angle closure; 2. Patietns with previous surgery resulted in Schlemm cannal disruption; 3. New vascular glaucoma; 4. Patients with serious heart or lung diseases; 5. Patients with abnormal liver or renal function or advanced tumors; 6. Women who are pregnant or preparing for pregnancy or lactation; 7. Patients who have participated in other clinical trials in the last three months; 8. Patients with uncontrolled hypertension; 9. Patients with uncontrolled diabetes; 10. No light perception; 11. Patients who are not fit this study through the investigator's evaluation.

Design outcomes

Primary

Measure	Time frame
Introcular Pressure;	—

Countries

China

Contacts

Public ContactWang Ningli

Beijing Tongren Hospital

wningli@vip.163.com+86 010-58269920

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026